Ethical Considerations in Personalized Nutrition for Inflammatory Bowel Diseases: Balancing Evidence, Accessibility, and Commercialization

This journal examines the development of personalized nutrition as an innovative approach in managing Inflammatory Bowel Diseases (IBD) amidst advancements in genomics and digital technology. The research aims to explore ethical aspects related to scientific validity, accessibility, and commercialization through a qualitative literature review method. The results indicate a gap in clinical evidence, disparities in access due to cost and technology, as well as risks of data privacy and algorithmic bias. Additionally, weak regulation and the dominance of commercial interests exacerbate ethical challenges. This study emphasizes the importance of strengthening governance, data protection, and equitable access to ensure that innovation can be applied responsibly.